1. Home
  2. NMRA vs MITT Comparison

NMRA vs MITT Comparison

Compare NMRA & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • MITT
  • Stock Information
  • Founded
  • NMRA 2019
  • MITT 2011
  • Country
  • NMRA United States
  • MITT United States
  • Employees
  • NMRA N/A
  • MITT N/A
  • Industry
  • NMRA
  • MITT Real Estate Investment Trusts
  • Sector
  • NMRA
  • MITT Real Estate
  • Exchange
  • NMRA Nasdaq
  • MITT Nasdaq
  • Market Cap
  • NMRA 268.5M
  • MITT 230.0M
  • IPO Year
  • NMRA 2023
  • MITT 2011
  • Fundamental
  • Price
  • NMRA $1.62
  • MITT $7.70
  • Analyst Decision
  • NMRA Buy
  • MITT Strong Buy
  • Analyst Count
  • NMRA 8
  • MITT 5
  • Target Price
  • NMRA $7.14
  • MITT $8.50
  • AVG Volume (30 Days)
  • NMRA 383.3K
  • MITT 155.0K
  • Earning Date
  • NMRA 11-11-2025
  • MITT 11-04-2025
  • Dividend Yield
  • NMRA N/A
  • MITT 10.89%
  • EPS Growth
  • NMRA N/A
  • MITT N/A
  • EPS
  • NMRA N/A
  • MITT 0.86
  • Revenue
  • NMRA N/A
  • MITT $83,509,000.00
  • Revenue This Year
  • NMRA N/A
  • MITT N/A
  • Revenue Next Year
  • NMRA N/A
  • MITT $14.05
  • P/E Ratio
  • NMRA N/A
  • MITT $8.99
  • Revenue Growth
  • NMRA N/A
  • MITT 25.02
  • 52 Week Low
  • NMRA $0.61
  • MITT $5.63
  • 52 Week High
  • NMRA $17.19
  • MITT $7.95
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 47.71
  • MITT 54.72
  • Support Level
  • NMRA $1.60
  • MITT $7.62
  • Resistance Level
  • NMRA $1.70
  • MITT $7.82
  • Average True Range (ATR)
  • NMRA 0.09
  • MITT 0.12
  • MACD
  • NMRA -0.01
  • MITT 0.02
  • Stochastic Oscillator
  • NMRA 8.51
  • MITT 64.71

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About MITT AG Mortgage Investment Trust Inc.

AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government-sponsored enterprise.

Share on Social Networks: